Sheaff Brock Investment Advisors LLC Takes $237,000 Position in Bruker Corporation (BRKR)

Sheaff Brock Investment Advisors LLC bought a new position in Bruker Corporation (NASDAQ:BRKR) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 8,227 shares of the medical research company’s stock, valued at approximately $237,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. SG Americas Securities LLC purchased a new position in shares of Bruker Corporation in the second quarter worth $111,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Bruker Corporation by 11.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,599 shares of the medical research company’s stock valued at $133,000 after purchasing an additional 467 shares during the period. Smithfield Trust Co. purchased a new position in Bruker Corporation during the 2nd quarter valued at $138,000. Capstone Asset Management Co. purchased a new position in Bruker Corporation during the 1st quarter valued at $203,000. Finally, Teacher Retirement System of Texas purchased a new position in Bruker Corporation during the 1st quarter valued at $209,000. 65.42% of the stock is currently owned by institutional investors.

Shares of Bruker Corporation (BRKR) opened at 30.05 on Wednesday. Bruker Corporation has a 52-week low of $19.59 and a 52-week high of $30.22. The stock has a market capitalization of $4.77 billion, a P/E ratio of 29.96 and a beta of 1.10. The stock has a 50 day moving average of $28.31 and a 200-day moving average of $26.33.

Bruker Corporation (NASDAQ:BRKR) last announced its quarterly earnings results on Thursday, August 3rd. The medical research company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.20 by $0.03. The firm had revenue of $414.90 million for the quarter, compared to analyst estimates of $384.75 million. Bruker Corporation had a return on equity of 26.66% and a net margin of 9.65%. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.20 earnings per share. Analysts predict that Bruker Corporation will post $1.12 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 22nd. Stockholders of record on Tuesday, September 5th will be paid a dividend of $0.04 per share. The ex-dividend date of this dividend is Thursday, August 31st. This represents a $0.16 annualized dividend and a dividend yield of 0.53%. Bruker Corporation’s dividend payout ratio is currently 16.00%.

A number of research analysts have issued reports on BRKR shares. BidaskClub raised shares of Bruker Corporation from a “hold” rating to a “buy” rating in a research report on Wednesday, August 16th. Wells Fargo & Company downgraded shares of Bruker Corporation from a “market perform” rating to an “underperform” rating in a research report on Wednesday, July 12th. Zacks Investment Research raised shares of Bruker Corporation from a “hold” rating to a “buy” rating and set a $33.00 price objective on the stock in a research report on Thursday, July 6th. Barclays PLC reissued an “equal weight” rating and set a $30.00 price objective (up from $26.00) on shares of Bruker Corporation in a research report on Monday, July 17th. Finally, Cowen and Company reissued a “hold” rating and set a $29.00 price objective on shares of Bruker Corporation in a research report on Friday, July 14th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $27.00.

In other news, CEO Frank H. Laukien purchased 2,335 shares of the business’s stock in a transaction dated Thursday, August 10th. The shares were purchased at an average price of $27.39 per share, for a total transaction of $63,955.65. Following the completion of the purchase, the chief executive officer now owns 37,791,386 shares in the company, valued at approximately $1,035,106,062.54. The purchase was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 35.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.themarketsdaily.com/2017/09/13/sheaff-brock-investment-advisors-llc-takes-237000-position-in-bruker-corporation-brkr.html.

Bruker Corporation Company Profile

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

Institutional Ownership by Quarter for Bruker Corporation (NASDAQ:BRKR)

Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply